Streptokinase–plasminogen activator complex kringle-dependent lysine-binding interface (SK-Pg LBS interface)

The Streptokinase–plasminogen activator complex kringle-dependent lysine-binding interface is a critical structural region formed during the non-proteolytic activation of plasminogen by the bacterial protein streptokinase. Unlike endogenous activators like tissue plasminogen activator (tPA), streptokinase forms a high-affinity 1:1 stoichiometric complex with plasminogen, inducing a conformational change that exposes the catalytic active site in the zymogen [1]. This interaction is heavily dependent on the lysine-binding sites (LBS) located within the kringle domains of plasminogen, which recognize specific residues on streptokinase [2]. This interface facilitates the assembly of the activator complex, which then proceeds to proteolytically convert additional plasminogen molecules into active plasmin [3]. In clinical practice, this mechanism is exploited for thrombolytic therapy to dissolve blood clots in conditions such as acute myocardial infarction and pulmonary embolism [3]. However, because streptokinase is a bacterial product, the complex is highly immunogenic and can lead to systemic fibrinolysis, increasing the risk of major bleeding [3, 4]. The interface represents a unique example of allosteric enzyme activation where a non-enzymatic cofactor transforms a zymogen into a functional protease [1].

Other names

Streptokinase-plasminogen lysine-binding siteSK-Pg kringle interaction interfacePlasminogen kringle-dependent streptokinase binding siteSK-Pg complex LBS

Allosteric induction of an active site in plasminogen through stoichiometric 1:1 complex formation, followed by proteolytic activation of substrate plasminogen [1, 2].